|
Novelix Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
109.21 Cr.
|
P/BV
|
3.80
|
Book Value (Rs.)
|
16.32
|
|
52 Week High/Low (Rs.)
|
70/25
|
FV/ML
|
10/1
|
P/E(X)
|
1,319.15
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.05
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -2.22 | -4.62 | -0.35 | -0.30 | -0.48 |
| Diluted EPS (Rs.) | -2.22 | -4.62 | -0.35 | -0.30 | -0.48 |
| Cash EPS (Rs.) | -2.48 | -4.36 | -0.08 | 0.07 | -0.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.48 | 9.09 | 13.74 | 14.10 | 14.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.48 | 9.09 | 13.74 | 14.10 | 14.29 |
| Revenue From Operations / Share (Rs.) | 10.63 | 11.41 | 12.65 | 12.91 | 12.97 |
| PBDIT / Share (Rs.) | -2.49 | -4.26 | 0.11 | 0.26 | 0.24 |
| PBIT / Share (Rs.) | -2.62 | -4.52 | -0.12 | 0.01 | -0.04 |
| PBT / Share (Rs.) | -2.62 | -4.60 | -0.26 | -0.15 | -0.24 |
| Net Profit / Share (Rs.) | -2.61 | -4.62 | -0.31 | -0.18 | -0.42 |
| NP After MI And SOA / Share (Rs.) | -2.22 | -4.62 | -0.34 | -0.29 | -0.48 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -23.46 | -37.38 | 0.88 | 2.08 | 1.91 |
| PBIT Margin (%) | -24.64 | -39.64 | -0.98 | 0.05 | -0.34 |
| PBT Margin (%) | -24.64 | -40.32 | -2.09 | -1.18 | -1.86 |
| Net Profit Margin (%) | -24.55 | -40.47 | -2.52 | -1.41 | -3.31 |
| NP After MI And SOA Margin (%) | -20.91 | -40.46 | -2.76 | -2.31 | -3.71 |
| Return on Networth / Equity (%) | -24.31 | -54.47 | -2.67 | -2.21 | -3.49 |
| Return on Capital Employeed (%) | -27.17 | -49.51 | -0.84 | 0.04 | -0.28 |
| Return On Assets (%) | -20.60 | -39.06 | -2.06 | -1.81 | -2.87 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.07 | 0.08 | 0.08 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.07 | 0.08 | 0.08 |
| Asset Turnover Ratio (%) | 0.10 | 0.08 | 0.08 | 0.27 | 0.24 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 6.38 | 3.37 | 6.30 | 10.87 | 11.17 |
| Quick Ratio (X) | 5.31 | 2.94 | 5.80 | 10.07 | 10.26 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | -54.51 | 0.79 | 1.68 | 1.25 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | -58.02 | -1.26 | -0.14 | -1.18 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 4.72 | 3.90 | 1.75 | 6.90 | 7.15 |
| EV / Net Operating Revenue (X) | 0.54 | 0.42 | 0.17 | 0.65 | 0.68 |
| EV / EBITDA (X) | -2.33 | -1.13 | 19.20 | 31.63 | 35.58 |
| MarketCap / Net Operating Revenue (X) | 0.83 | 0.59 | 0.15 | 0.54 | 0.58 |
| Price / BV (X) | 0.97 | 0.79 | 0.14 | 0.51 | 0.54 |
| Price / Net Operating Revenue (X) | 0.83 | 0.59 | 0.15 | 0.54 | 0.58 |
| EarningsYield | -0.24 | -0.68 | -0.17 | -0.04 | -0.06 |
